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ABSTRACT 
A proportion of cutaneous melanomas display neval remnants on histologic examination. 
Converging lines of epidemiologic and molecular evidence suggest that melanomas arising from 
nevus precursors differ from melanomas arising de novo. In a large, population-based study 
comprising 636 cutaneous melanomas subjected to dermatopathology review, we explored the 
molecular, host and environmental factors associated with the presence of neval remnants. We 
found nevus-associated melanomas were significantly associated with younger age at 
presentation, non-brown eye color, trunk site, thickness <0.5mm and BRAFV600E mutation. 
Compared with patients with de novo melanomas, those with nevus-associated tumors were more 
likely to self-report many moles on their skin as a teenager (OR 1.94, 95% CI 1.01-3.72) but less 
likely to report many facial freckles (OR 0.49, 95% CI 0.25-0.96). They also had high total 
nevus counts (OR 2.18, 95% CI 1.26-3.78). On histologic examination, nevus-associated 
melanomas exhibited less dermal elastosis in adjacent skin compared with de novo melanomas 
(OR 0.55, 95% CI 0.30-1.01). These epidemiologic data accord with the emerging molecular 
paradigm that nevus-associated melanomas arise through a distinct sequence of causal events 
which differ from those leading to other cutaneous melanomas. 
 
ABBREVIATIONS 
CI, Confidence Interval; LMM, Lentigo Maligna Melanoma; NM: Nodular Melanoma; OR, 
Odds-Ratio; SSM: Superficial Spreading Melanoma 
KEYWORDS 
cutaneous melanoma; epidemiology; melanocytic nevus; neval remnants; pigmentation; sun 
exposure 
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INTRODUCTION 
The incidence of cutaneous melanoma, a potentially lethal cancer, has risen rapidly over recent 
decades in most countries with fair-skinned populations (Whiteman et al., 2016). Understanding 
the mechanisms through which these cancers arise is necessary for effective preventive strategies 
to be developed. Converging lines of evidence from epidemiologic and molecular studies suggest 
that cutaneous melanomas arise through at least two causal pathways: one of which is associated 
with chronic exposure to sunlight, and the other associated with host propensity to develop large 
numbers of melanocytic nevi (Shain and Bastian, 2016, Whiteman et al., 2011).  
 
It has long been recognized that a proportion of cutaneous melanomas have evidence of 
contiguous neval remnants on histologic examination (hereafter “nevus-associated melanomas”), 
though the exact proportion is debated (Haenssle et al., 2016, Marks et al., 1990, Massi et al., 
1999, Skender-Kalnenas et al., 1995). A recent meta-analysis of 38 observational studies 
reported a summary prevalence estimate of 29.1% of melanomas had adjacent neval remnants, 
although there was significant heterogeneity across studies (Pampena et al., 2017) . It was thus 
assumed that these nevus-associated melanomas arose by ‘carcinogenic evolution’ from the pre-
existing benign lesion (Ackerman, 1980). Recent studies mapping the genomic profiles of 
melanocytic lesions displaying regions of benign, dysplastic and neoplastic architecture bear out 
this assumption (Shain and Bastian, 2016). A small number of earlier studies reported 
differences in phenotypic (Bevona et al., 2003, Carli et al., 1999, Chang et al., 2009, Haenssle et 
al., 2016, Kaddu et al., 2002) and environmental (Newton-Bishop et al., 2010, Purdue et al., 
2005, Sergentanis et al., 2013) risk factors between nevus-associated melanomas and non-nevus 
melanoma, consistent with the two-pathway model. We sought to explore the molecular, host 
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and environmental factors correlated with nevus-associated melanomas in a large, population-
based study, by comparing them with non-nevus melanomas. 
 
RESULTS 
Of 1456 melanoma patients invited, 808 gave consent to participate and pathology reports were 
retrieved for 807 patients. Figure 1 shows the details on the number of patients excluded upon 
pathology review and the subsequent study sample. After excluding all patients with lentigo 
maligna melanoma (n=99) from the primary analysis, as well as those with ineligible sites or 
types (n=42) and melanomas for which neval remnant status was unclassifiable due to 
insufficient adjacent tissue or artefact (n=30), our primary analysis study sample comprised 636 
melanoma patients. BRAF mutation status was able to be determined in 393 tumors; the 
remainder either had insufficient material remaining in the blocks, or were not available for 
analysis. 
 
There were 523 patients with trunk melanomas and 113 with head and neck melanomas. The 
average age of the patients was 56 years (SD 14.3) and two thirds (67%) were men. Most of the 
melanomas were of the superficial spreading (SSM) subtype (83%) and slightly over half (54%) 
had a Breslow thickness of 0.5mm or less. BRAFV600E mutations were detected in 102 of 393 
melanomas (26%) for which sufficient material was available for somatic mutation analysis.  
 
Contiguous neval remnants were present in just over half of the melanomas (n=324, 51%). 
Patients with nevus-associated melanomas were younger on average (mean age: 53.7 years) than 
those with non-nevus melanomas (59.3 years). Nevus-associated melanomas were more common 
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on the trunk compared with the head and neck (54% vs 35% respectively within each site). Of 
the head and neck melanomas, 24 (21%) occurred on the scalp, and these melanomas had a lower 
prevalence of neval remnants (21%) than those arising on the face and neck (38%). Nevus-
associated melanomas were also more common among SSM subtype than other subtypes, and 
were more likely to be thin (≤0.5mm) or to harbor BRAFV600E mutations than non-nevus 
melanomas (Table 1). All of these factors remained statistically significant after adjusting for age 
and sex.  
 
With regard to phenotypic characteristics, when unadjusted, the prevalence of nevus-associated 
melanoma was slightly higher among patients with blond hair color and green/hazel eye color, 
but did not vary significantly with propensity to burning or tanning skin type (Table 2). The odds 
of nevus-associated melanoma increased significantly with numbers of moles on the skin as a 
teenager [self-reported] and with nevus counts [by skin examination], but decreased significantly 
with numbers of freckles on the face as a teenager [self-reported]. We found a lower prevalence 
of marked dermal elastosis in the skin adjacent to the nevus-associated melanomas compared 
with non-nevus melanomas (Table 2). 
 
Of the various reported and derived measures of sun exposure, total hours of sun exposure and 
total hours of occupation sun exposure were inversely associated with nevus associated 
melanomas in unadjusted models, however the statistical significance was lost after adjustment 
for age and sex (Table 3). We observed no notable differences in the prevalence of nevus-
associated melanomas across categories of recreational or childhood sun exposures, or numbers 
of sunburns in various periods of life.  
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To estimate the direct effects of the factors associated with nevus-associated melanoma, we 
developed multivariable models adjusting for the potential confounding effects of other factors. 
Our final model consisted of a reduced list of histological (anatomic site, tumor thickness and 
degree of dermal elastosis) and phenotypic factors (eye color, number of freckles and total body 
nevus counts), as well as BRAFV600E mutation status.  Not unexpectedly, several pairs of factors 
were highly correlated, requiring careful selection of terms to retain in the final model. For 
example, ‘number of moles as a teenager’ was dropped from the model when the term for ‘total 
body nevus counts’ was included. Given these two factors measure the same underlying trait (i.e. 
‘propensity to develop nevi’), we retained total nevus count in the model as the stronger term. 
Anatomical site and grade of dermal elastosis were also correlated (spearman rho 0.53, P<0.001), 
and both were statistically significant when included singly in the multivariable model, but each 
weakened the other when included together in the model. However, we retained both factors in 
the final model as they are measuring different characteristics despite their correlation, and each 
could strongly confound the other. 
 
Thus, in the final model, factors significantly associated with nevus-associated melanoma were 
age, eye color, tumor thickness, freckles as a teenager and nevus count, while tumor site and 
dermal elastosis only marginally missed statistical significance at the 5% level (Table 4). The 
strongest predictor of nevus-associated melanoma was total nevus count, and the strongest 
predictors of non-neval melanomas were many facial freckles as a teenager, age >70 years, and 
marked dermal elastosis in the adjacent epidermis.  
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
8 
 
In analyses stratified by site of melanoma (trunk, head-neck), the distribution of factors 
according to nevus-association were similar for both sites (Table 5) except for self-reported 
number of nevi as a teenager, for which the odds ratios differed significantly across the sites. 
Although the observed association was stronger for nevus count and tumor thickness for trunk 
melanomas compared to head and neck, the limited number of nevus-associated melanomas on 
the head and neck meant that the analysis lacked statistical power for further assessment. 
 
Supplementary analysis 
We repeated our analyses including the 94 patients (5 LMMs were missing neval remnant 
classification, Figure 1) diagnosed with LMM who were excluded from the primary analysis 
(Supplementary Tables 1-5). Including the LMM cases made no difference to the list of factors 
associated with neval remnants when compared to the primary analysis, except for the inclusion 
of histological subtype (LMM subtype was significantly less likely to have contiguous neval 
remnants compared with SMM; Supplementary table 1). For all other factors, the effect estimates 
from the supplementary analysis were comparable to those from the primary analysis, except that 
the effects of age, anatomic site, dermal elastosis and nevus count were more pronounced.  
 
DISCUSSION 
We assessed the prevalence of nevus-associated melanomas and explored the factors associated 
with their presence, on the assumption that these malignant melanocytic tumors evolve directly 
from pre-existing benign lesions. We found that approximately half (51%) of the invasive 
melanomas in this series from two anatomic sites had neval remnants. Overall, nevus-associated 
melanomas were more likely to occur in younger individuals, and those with green or blue eye 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
9 
 
color, no or few freckles as a teenager, and high nevus counts. They were also significantly less 
likely than non-nevus melanomas to show signs of chronic sun damage. These associations were 
observed both for melanomas occurring on the trunk and on the head or neck, tending to confirm 
the associations reported previously (Bevona et al., 2003, Haenssle et al., 2016, Lee et al., 2006, 
Purdue et al., 2005, Shitara et al., 2014).  
 
The prevalence of contiguous remnants in the present series was at the higher end of the range 
reported in the literature (9% to 58%) (Bevona et al., 2003, Carli et al., 1999, Haenssle et al., 
2016, Lin et al., 2015), and was substantially higher than the summary prevalence estimate of 
29.1% reported by Pampena et al (Pampena et al., 2017). It must be noted that our series was 
restricted to melanomas of the trunk and head and neck. Although Pampena et al (Pampena et al., 
2017) did not report the pooled prevalence of continguous neval remnants according to the 
anatomic site of the melanoma, we reviewed the primary publications and derived summary site-
specific prevalence estimates of 38% (range 23% to 64%) for melanomas of the trunk and 18% 
(range 0% to 30%) for melanomas of the head and neck. Of note, there was highly significant 
heterogeneity of nevus prevalence across studies, suggesting substantial variation in this feature. 
The site-specific prevalence of neval remnants observed in this population-based series of 
melanomas in Queensland broadly aligns with those observed elsewhere, being markedly higher 
on the trunk than the head and neck. 
 
We intentionally restricted recruitment of patients to two anatomical sites, as a priori our 
objective was to quantify associations between melanomas grouped according to specific 
histologic characteristics. Assuming a fixed sample size, the greatest statistical power for 
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examining associations is gained by sampling participants from the extremes of a distribution. In 
this particular study of cutaneous melanoma, the extremes of exposure were ‘habitually sun 
exposed sites’ and ‘habitually covered sites’. Typically, in Australian adults of both sexes, the 
limbs are uncovered by clothing and exposed to the sun to a greater extent than the trunk, but 
less than the face, ears, head and neck. Thus, for reasons of statistical efficiency, the sampling 
frame was restricted to patients with melanomas of the head or trunk only, and did not include 
patients with melanomas of the limbs, palms, soles or other sites. We also excluded melanomas 
of the lentigo maligna subtype from our primary analyses on the grounds that these were already 
known to be associated with chronic solar exposure and not with nevi. While our subsequent 
analysis including LMMs made no difference to our conclusions about the differences between 
nevus-associated and non-nevus melanomas, their inclusion naturally reduced the prevalence of 
contiguous neval remnants. For these reasons, the prevalence figures for nevus-associated 
melanoma reported here are not generalizable to all melanomas, and are only comparable to 
those case series which have reported site-specific prevalence of invasive, nevus-associated 
melanoma.  
 
By restricting our sample only to patients with melanomas of the trunk or head and neck, we also 
may have limited the generalizability regarding factors correlated with nevus-associated 
melanoma. Specifically, it is conceivable that nevus-associated melanomas arising on the upper 
or lower limbs may differ from nevus-associated melanomas arising elsewhere, although there is 
no reason to assume so. Indeed, the effect sizes we observed for nevus-associated melanomas on 
the trunk were similar to those observed for melanomas on the head & neck, suggesting that the 
factors predicting nevus-associated melanomas (namely young age, thin lesions, nevus density 
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and BRAF mutations) operate independently of the anatomic site of the melanoma. Confirming 
these site-specific associations in statistically powered, purpose-designed studies would resolve 
any uncertainty in this regard. 
 
Our understanding of the origins of cutaneous melanomas has progressed rapidly in recent years. 
Whereas in earlier generations of epidemiologic studies, patients with cutaneous melanomas 
were typically analyzed as a single homogenous group, it became apparent that not all cutaneous 
melanomas share the same causal origins. Descriptive (Elwood and Gallagher, 1998, Lachiewicz 
et al., 2008) and analytical (Whiteman et al., 2006, Whiteman et al., 2003) epidemiologic studies 
first suggested that melanomas may be grouped according to their age of onset, anatomical site 
and other host characteristics. More recently, molecular and genomic studies have mapped the 
pathways through which mutations in key driver genes drive neoplastic progression in 
melanocytes. There is now convincing evidence that a proportion of melanomas arise directly 
from benign precursors (nevi) that carry distinctive BRAFV600E mutations (Shain and Bastian, 
2016, Shain et al., 2015). Most of these lesions remain in a state of induced senescence however 
a very small proportion of lesions acquire additional mutations in key driver genes (e.g. 
CDKN2A, TERT) which herald the onset of more several dysplastic properties. It appears that the 
steps to invasive and potentially metastatic melanoma requires only one or two additional 
mutations (e.g. ARID, ATM, TP53, PTEN etc) (Shain and Bastian, 2016). This sequential 
pathway of acquired somatic mutations appears to fit well with the model of progression from 
benign nevus to in situ melanoma to invasive melanoma. Our data, collated from a large 
population-based series of melanoma cases, demonstrate a significant association between 
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BRAFV600E mutation and nevus-associated melanoma and thus accord with the molecular model 
described.  
 
A large proportion of melanomas, likely the majority, do not arise through the nevus pathway 
described above. Our data, and others, show that melanomas arising through the non-nevus 
pathway are associated with older age, nodular subtype, higher Breslow thickness, location on 
the head or neck, dermal elastosis and low nevus count (Pampena et al., 2017). The associations 
with age, habitually exposed body sites and dermal elastosis lead us to infer that high levels of 
cumulative sun exposure cause these non-nevus melanomas. Nodular melanomas have also been 
associated with high levels of sun exposure (Mar et al., 2013). Although the inverse association 
with nevus-prone phenotype could, in theory, be explained by age differences in the two groups 
of melanoma patients (given that nevus counts are highest in young adults and low in older 
people), we believe this explanation is unlikely as our analyses were adjusted for age.  
 
Several explanations have been offered as to how non-nevus melanomas might arise. One 
explanation is that such melanomas do arise from a prior nevus, but then the benign lesion is 
overgrown by the invasive, malignant tumor, removing any trace of its prior existence. The 
association with higher Breslow thickness fits with this model. An alternative explanation, now 
supported by sequencing data, is that the non-nevus melanomas arise through different mutations 
in the MAPK pathway (Shain and Bastian, 2016, Shain et al., 2015). It seems that these 
melanomas can have a rapid clinical onset (as has long been clinically recognized for nodular 
melanomas). 
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What do these epidemiologic data offer by way of insights to the new molecular paradigm? First, 
they underscore the importance of host phenotype in governing susceptibility (or alternatively, 
resistance) to melanoma development. Of all the factors assessed here, it is the association with 
nevus number that was the strongest predictor of nevus-associated melanoma, and the most 
consistent with other studies. Understanding why some people are more prone to develop nevi 
than others has long been the focus of research. Despite the significant contributions of sun 
exposure, the heritability of nevus count has been estimated by twin studies to be in the range of 
60-90% (Zhu et al., 1999). The latter high estimate is for adolescent twins all living in a high UV 
environment in Australia, where one presumes environmental differences in exposure are 
minimized. Within these twin collections, it has been recently shown that ~25% of the Australian 
and ~15% of British genetic variance for nevus count can be explained by a panel of 1,000 SNPs 
covering 32 genomic regions. Given that nevi are precursors to melanomas, at least in some 
people, unravelling the biology of these lesions remains an important research goal.  
 
Second, these data remind us that a large proportion of melanomas are not associated with neval 
remnants, and arise on the skin of people who may not have the classical ‘high-risk’ phenotype 
for melanoma. Moreover, it appears that this subset of melanomas includes the majority of 
rapidly invasive, potentially lethal nodular melanomas. Together, these two points suggest that 
efforts to control melanoma mortality through early detection programs may have limited 
capacity to reduce mortality if risk stratification is based largely on phenotype. 
 
The associations described in this report are strong, due in part to a large sample size compared 
with earlier studies. Care was taken to explore the correlations within the data, and we are 
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satisfied that the associations reported here are unlikely to reflect the confounding effects of 
other factors. Further strengths of this study include the population-based ascertainment of cases, 
and the systematic reporting of histologic criteria by expert dermato-pathologists who were 
unaware of patient phenotype or sun exposure histories. Although it can be argued that using 
self-reported phenotype data from patients is a limitation, we have shown that very similar data 
collection instruments that we have used in other studies have very high repeatability and 
validity for these items (Morze et al., 2012).  
 
Understanding the origins of melanoma is essential for tailoring control programs to maximum 
effect. These observations align with recent developments in melanoma biology, and underscore 
the diversity of pathways through which malignancies can arise from melanocytes. Weaving 
such knowledge into melanoma prevention strategies will be essential to ensuring that such 
efforts will have the desired effects. 
 
MATERIALS AND METHODS 
The parent study was designed specifically to test for differences in causal factors between 
cutaneous melanomas arising on habitually sun-exposed body sites (viz. head, face and neck), 
and those melanomas arising on habitually covered body sites (viz. trunk). Thus, the study was a 
case-case design, and did not include population controls. This approach provides maximum 
statistical efficiency for addressing this research question when the sample size is fixed since it 
ensures that patients with melanoma are sampled from body sites at each end of the range of 
typical sun exposure. For the analyses in this report, patients with melanoma arising on either of 
these two anatomic sites were placed into two groups based on the contiguous neval remnant 
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status of their melanoma (‘nevus-associated melanoma’ and ‘non-nevus melanoma’) and then 
compared for risk factors. Patients with incident diagnoses of invasive primary cutaneous 
melanoma were prospectively ascertained from diagnoses made in the main pathology 
laboratories serving southern Queensland. The Human Research Ethics Committee of the QIMR 
Berghofer Medical Research Institute granted ethical approval for the study and all patients gave 
their written informed consent.  
  
Patient eligibility and histologic criteria 
Full details of patient recruitment and exposure measurement have been reported previously 
(Kvaskoff et al., 2015). Briefly, eligible patients were residents of greater Brisbane aged 18-79 
years who were diagnosed with primary invasive cutaneous melanoma arising on the face, head, 
neck, or trunk between April 1, 2007 and September 30, 2010.  
 
Patients with metastatic disease or a previous diagnosis of melanoma were ineligible. At the time 
of diagnosis, collaborating dermato-pathologists assessed tumor’s anatomical site, histological 
type, tumor thickness, extent of dermal elastosis in the skin adjacent to the tumor and the 
presence of neval remnants in the skin surrounding each melanoma using a standard scoring 
sheet including definitions for scored items. Contiguous neval remnants were defined as the 
presence of nests, sheets, cords and/or single-file disposition of cytologically benign nevus cells 
in the dermis adjacent to or below (subjacent) the melanoma cells. Similarly, dermal elastosis 
was defined in four categories of none, mild (characterized by proliferation of elastic fibers in the 
papillary dermis), moderate or marked elastosis (papillary and upper reticular dermis is replaced 
by accumulations of thickened, curled and serpiginous fibers forming tangled masses which are 
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basophilic in HE-stained sections). Full details of the BRAF mutation analysis have been 
provided previously (Hacker et al., 2016), but briefly, tumor DNA was isolated from samples of 
melanoma material that had been dissected from formalin-fixed paraffin-embedded sections. 
Genotyping was performed on a mass spectrometric platform using an optimized multiplex assay 
(MelaCarta Panel, Agena Bioscience, San Diego, CA).  
 
Phenotype and sun exposure  
Participants completed a detailed self-administered questionnaire and then underwent a clinical 
examination by the study dermatologist. In addition to basic demographic details (including 
place of birth and age at migration to Australia, if applicable), participants self-reported their hair 
color as a teenager, burning tendency, tanning ability, facial freckling as a teenager and nevus 
burden as a teenager. To assess chronic sun damage, participants were asked to report the 
number of actinic keratoses that had been treated. We asked separately about treatments for “skin 
cancers”, and recorded responses for the number of lesions that had been treated by freezing, 
creams, excision, and other means.  
 
Participants were also asked to report patterns of sun exposure while attending elementary school 
and high school on week days and weekends, and to report the number of times they were 
sunburned to the point of blistering, soreness for 2 days or more, or peeling while attending 
elementary school, high school, and since leaving school. A comprehensive occupational sun 
exposure history was obtained (including periods of study and unemployment). Participants were 
asked to list the number of jobs, their start, end age and the number of days per week worked in 
each job including number of hours spent outdoor on work and non-workdays in three broad 
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categories Weights were assigned to each of the categories of outdoor sun exposure as follows: 
“<1 hour per day”, 0.5 hours; “1 to 4 hours per day”, 2 hours; “>4 hours per day”, 6 hours. We 
calculated the hours of occupational and recreational sun exposure by multiplying the number of 
hours per day spent outdoors in the sun on workdays and non-work days respectively in each 
employment period. We summed hours of occupational and recreational sun exposures across all 
employment periods between 18 and 70 years of age to derive the total number of hours of sun 
exposure for each participant. These factors were categorized into quartiles for the analysis.  
 
After completing the questionnaire, each participant was examined by a dermatologist (M.B.D.) 
who recorded hair and eye color and counted the number of melanocytic nevi and actinic 
keratoses according to standard protocols (English et al., 1990). 
 
Statistical analysis 
The primary aim of this analysis was to identify phenotypic and environmental risk factors for 
nevus-associated melanoma, and assess whether the factors differed by the anatomical site of the 
melanoma.  
 
Missing dermal elastosis data 
Information on dermal elastosis, a histological marker of chronic sun exposure, was missing for 
around 10% of our sample. Rather than exclude these participants from the analyses, we imputed 
data. For our primary analysis, we assumed the dermal elastosis data were missing at random and 
used multiple regression to impute the missing data on dermal elastosis. We used 25 imputations 
for stability. We also performed sensitivity analyses to assess the potential impact of missing 
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dermal elastosis data. We assigned all those with missing dermal elastosis data to the “none or 
mild” category, under the assumption that “not reported” equated to “no elastosis”.  
 
Model fitting 
We analyzed presence or absence of contiguous neval remnants as a binary outcome. We 
calculated odds ratios (ORs) and 95% confidence intervals (CIs) using unconditional logistic 
regression models to quantify the association between histologic, phenotypic factors, BRAF 
mutation status and presence of neval remnants. We first fitted simple models adjusting only for 
age and sex. Then we included in the model those factors significant at the 10% level of 
significance. (To rule out overfitting, we also constructed directed acyclic graphs to assess 
potential confounding. No changes were made to the model following this process, data not 
shown). Our final model consisted of age and variables that were statistically significant at the 
10% level in the fully adjusted model.  Where relevant, we performed tests for linear trend using 
an ordinal score for categories of ordinal factors. Each of the imputed datasets were analyzed 
separately and the estimates were pooled using Rubin’s rules (Rubin, 2004). We report the 
pooled (imputed) estimates. 
 
To test whether factors associated with contiguous neval remnants differed according to the 
tumor’s anatomical site, we included interaction terms for each significant variable in the final 
model. We also performed site stratified analysis of variables in our final multivariable model 
and tested for homogeneity in the odds ratios across anatomical sites (Hosmer and Lemeshow, 
2000).  
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Statistical analyses were performed using the SAS statistical package, version 9.3 (SAS Institute, 
Inc, Cary, NC).  
 
Supplementary analysis 
Our primary analysis excluded LMMs as they are known to be related to chronic sun exposure 
and rarely with contiguous neval remnants, and to occur predominantly on the head and neck. By 
including them, sun exposure related factors were more likely to take precedence over other 
factors on the outcome.  However, most previous studies assessing factors associated with neval 
remnants included LMMs. Hence we performed supplementary analysis by repeating our 
analysis including 94 LMMs with complete data on neval remnant status so our results could be 
compared with the other published studies. 
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Table 1. Distribution of age, sex and histological factors and association with nevus-
associated melanoma (n=636) 
 Presence of Nevus  Age and sex  
adjusted 
 No (n=312) Yes (n=324)  
Variables n (%) n (%) P value OR (95% CI) 
Age at diagnosis     
 <50  67 (21.5) 121 (37.3)  Reference 
 50-59  72 (23.1) 69 (21.3)  0.53 (0.34 – 0.84) 
 60-69  94 (30.1) 88 (27.2)  0.52 (0.34 – 0.80) 
 ≥70  79 (25.3) 46 (14.2) <0.001 0.32 (0.20 – 0.53) 
Sex     
 Female  93 (29.8) 114 (35.2)  Reference 
 Male 219 (70.2) 210 (64.8) 0.15 0.99 (0.70 -1.43) 
Anatomical site      
 Head and Neck  74 (23.7) 39 (12.0)  Reference 
 Trunk 238 (76.3) 285 (88.0) <0.001 2.35 (1.52 – 3.64) 
Histological type     
 SSM 249 (79.8) 278 (85.8)  Reference 
 NM  25 (8.0) 11 (3.4)  0.42 (0.20 – 0.89) 
 Other  38 (12.2) 35 (10.8) 0.03 0.80 (0.49 – 1.32) 
Tumor thickness     
 ≤0.05mm 147 (47.1) 195 (60.2)  Reference 
 >0.05mm 165 (52.9) 129 (39.8) <0.001 0.58 (0.42 – 0.80) 
BRAFV600E mutation     
 No 167 (41.9) 124 (37.5) <0.001 Reference 
 Yes  34 (8.5)  68 (20.5)  1.98 (1.18 – 3.31) 
 Missing 198 (49.6) 139 (42.0)  1.13 (0.80 – 1.60) 
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Table 2. Distribution of phenotypic factors and association with the nevus-associated 
melanoma (n=636) 
 
Presence of Nevus  Age and sex  
adjusted No (n=312) Yes (n=324)  
Variables n (%) n (%) P value OR (95%CI) 
Hair color as teenager     
 Black/dark brown 107 (34.4) 93 (28.7)  Reference 
 Blond 60 (19.3) 84 (25.9)  1.47 (0.95 - 2.29) 
 Light brown 97 (31.2) 107 (33.0)  1.29 (0.87 – 1.92) 
 Red/auburn/strawberry 47 (15.1) 40 (12.3) 0.12 0.96 (0.57 - 1.61) 
Eye color     
 Brown 54 (17.3) 42 (13.0)  Reference 
 Blue/Grey 199 (63.8) 208 (64.2)  1.58 (0.99 – 2.51) 
 Green/Hazel  59 (18.9) 74 (22.8) 0.21 1.68 (0.97 – 2.89) 
Burning reaction to skin     
 Never/Rarely burns 28 ( 9.0) 30 ( 9.3)  Reference 
 Sometimes burns 92 (29.5) 98 (30.2)  0.81 (0.44 - 1.48) 
 Mostly burns 87 (27.9) 87 (26.9)  0.73 (0.39 - 1.35) 
 Always burns 105 (33.7) 109 (33.6) 0.99 0.71 (0.39 - 1.31) 
Tanning reaction to skin     
 No tan 32 (10.3) 34 (10.5)  Reference 
 Light tan 93 (29.8) 85 (26.2)  0.90 (0.50 - 1.60) 
 Moderate tan 141 (45.2) 147 (45.4)  1.05 (0.60 – 1.82) 
 Deep tan 46 (14.7) 58 (17.9) 0.64 1.28 (0.68 - 2.43) 
Freckles on face as teenager     
 None 104 (33.3) 115 (35.5)  Reference 
 Few  110 (35.3) 141 (43.5)  1.02 (0.70 - 1.48) 
 Some  57 (18.3) 49 (15.1)  0.66 (0.41 - 1.08) 
 Many  41 (13.1) 19 ( 5.9) 0.01 0.34 (0.18 - 0.64) 
Moles on skin as a teenager     
 None 71 (22.8) 43 (13.3)  Reference 
 Few  138 (44.2) 129 (39.8)  1.33 (0.84 – 2.11) 
 Some  75 (24.0) 99 (30.6)  1.71 (1.03 – 2.83) 
 Many  28 (9.0) 53 (16.4) <0.001 2.32 (1.25 – 4.31) 
Total nevus count by 
dermatologist 
    
 <35 101 (32.4) 58 (17.9)  Reference 
 35-64 81 (26.0) 68 (21.0)  1.42 (0.89 - 2.28) 
 65-134 80 (25.6) 83 (25.6)  1.63 (1.01 - 2.63) 
 ≥135 50 (16.0) 115 (35.5) <.001 3.40 (2.03 – 5.72) 
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Presence of Nevus  Age and sex  
adjusted No (n=312) Yes (n=324)  
Variables n (%) n (%) P value OR (95%CI) 
Degree of dermal elastosis     
 Nil or Mild 137 (46.9) 188 (67.4)  Reference 
 Moderate 81 (27.7) 62 (22.2)  0.65 (0.42 – 1.01) 
 Marked 74 (25.3) 29 (10.4) <0.001 0.34 (0.20 – 0.57) 
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Table 3. Distribution of sun exposure factors and association with the nevus-associated 
melanoma (n=636) 
 
Presence of Nevus  Age and sex 
adjusted No (n=312) Yes (n=324)  
Variables n (%) n (%) P value OR (95%CI) 
     
Total number of hours of sun 
exposure 
    
Quartile1 58 (18.6) 104 (32.1)  Reference 
 Quartile2 82 (26.3) 75 (23.1)  0.65 (0.40 - 1.06) 
 Quartile3 84 (26.9) 75 (23.1)  0.70 (0.42 - 1.19) 
 Quartile4 88 (28.2) 70 (21.6) 0.001 0.67 (0.38 - 1.17) 
Number of hours of 
occupational sun exposure 
    
 Quartile1 56 (17.9) 103 (31.8)  Reference 
 Quartile2 81 (26.0) 82 (25.3)  0.70 (0.43 - 1.14) 
 Quartile3 83 (26.6) 71 (21.9)  0.64 (0.38 - 1.06) 
 Quartile4 92 (29.5) 68 (21.0) <0.001 0.60 (0.35 - 1.04) 
Number of hours of 
recreational sun exposure 
    
 Quartile1 80 (25.6) 79 (24.4)  Reference 
 Quartile2 84 (26.9) 69 (21.3)  0.85 (0.53 - 1.35) 
 Quartile3 70 (22.4) 89 (27.5)  1.14 (0.72 - 1.82) 
 Quartile4 78 (25.0) 87 (26.9) 0.26 1.12 (0.70 - 1.79) 
Number of sunburns in 
primary school 
    
 Never or 1-5 times 120 (38.6) 106 (32.8)  Reference 
 6-10 times 79 (25.4) 79 (24.5)  1.12 (0.74 - 1.69) 
 10+times 112 (36.0) 138 (42.7) 0.19 1.32 (0.91 - 1.91) 
Number of sunburns in 
secondary school 
    
 Never or 1-5 times 137 (48.2) 135 (43.7)  Reference 
 6-10 times 71 (25.0) 80 (25.9)  1.07 (0.72 - 1.61) 
 10+times 76 (26.8) 94 (30.4) 0.50 1.05 (0.70 - 1.57) 
Number of sunburns since 
leaving school 
    
 Never or 1-5 times 145 (46.6) 157 (48.8)  Reference 
 6-10 times 54 (17.4) 64 (19.9)  1.02 (0.66 - 1.58) 
 10+times 112 (36.0) 101 (31.4) 0.43 0.80 (0.56 - 1.15) 
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Table 4. Adjusted odds-ratios (ORs) and 95% confidence intervals (CIs) for factors 
associated with nevus-associated melanoma. 
Variables1 OR (95%CI) 
Age at diagnosis  
 <50 Reference 
 50-59 0.62 (0.38 – 1.02) 
 60-69 0.77 (0.46 - 1.28) 
 ≥70 0.58 (0.32 – 1.06) 
Anatomical site3   
 Head and Neck Reference 
 Trunk 1.61 (0.95 - 2.76) 
Tumor thickness  
 ≤0.5mm Reference 
 >0.5mm 0.61 (0.43 - 0.85) 
Eye color  
 Brown Reference 
 Blue/Grey 1.80 (1.11 - 2.94) 
 Green/Hazel  1.84 (1.04 - 3.28) 
Freckles on face as teenager  
 None Reference 
 Few  1.08 (0.73 - 1.61) 
 Some  0.84 (0.50 - 1.41) 
 Many  0.49 (0.25 - 0.96) 
Moles on skin as a teenager2  
 None Reference 
 Few  1.19 (0.73 - 1.94) 
 Some  1.36 (0.79 - 2.33) 
 Many  1.94 (1.01 – 3.72) 
Total nevus count by dermatologist2  
 <35 Reference 
 35-64 1.27 (0.78 - 2.09) 
 65-134 1.23 (0.74 - 2.04) 
 ≥135 2.18 (1.26 - 3.78) 
Degree of dermal elastosis3  
 Nil or Mild Reference 
 Moderate 0.69 (0.44 - 1.09) 
 Marked 0.55 (0.30 – 1.01) 
BRAFV600E mutation4  
 No Reference 
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Variables1 OR (95%CI) 
 Yes 1. 87 (1.08 – 3.23) 
1ORs are adjusted for all variables in the table except for 2moles and total nevus count not adjusted for each other.  
3The OR (95%CI) for anatomical site in absence of degree of dermal elastosis in the model was 2.07 (1.31 -3.28). Similarly, the 
effect of dermal elastosis in absence of anatomical site in the model was 0.66 (0.42 – 1.03) for moderate and 0.42 (0.25 – 0.71) 
for marked elastosis. 4BRAF missing category was included in the model as a separate category. 
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Table 5. Adjusted odds-ratios (ORs) and 95% confidence intervals (CIs) for factors 
associated with nevus-associated melanoma, stratified by body site. 
 
Trunk Head and Neck 
Variables OR (95%CI) OR (95%CI) 
Age at diagnosis   
 <50 Reference Reference 
 50-59 0.54 (0.32 - 0.93) 1.60 (0.39 – 6.64) 
 60-69 0.79 (0.45 - 1.38) 0.65 (0.17 - 2.57) 
 ≥70 0.60 (0.31 - 1.18) 0.45 (0.10 - 2.10) 
Tumor thickness   
 ≤0.5mm Reference Reference 
 >0.5mm 0.55 (0.38 - 0.80) 0.88 (0.387 - 2.11) 
Eye color   
 Brown Reference Reference 
 Blue/Grey 1.87 (1.10 - 3.16) 1.60 (0.36 – 7.17) 
 Green/Hazel  1.72 (0.92 - 3.21) 2.47 (0.49 - 12.41) 
Freckles on face as teenager   
 None Reference Reference 
 Few  1.13 (0.73 - 1.74) 0.88 (0.31 - 2.51) 
 Some  0.85 (0.49 - 1.49) 0.59 (0.14 - 2.52) 
 Many  0.49 (0.23 - 1.05) 0.48 (0.11 – 2.16) 
Moles on skin as a teenager1   
 None Reference Reference 
 Few  1.26 (0.73 - 2.17) 1.02 (0.33 - 3.12) 
 Some  1.69 (0.94 - 3.07) 0.21 (0.04 - 1.14) 
 Many  2.14 (1.05 - 4.36) 1.19 (0.18 - 7.78) 
Total nevus count by dermatologist   
 <35 Reference Reference 
 35-64 1.29 (0.74 - 2.25) 1.16 (0.38 - 3.59) 
 65-134 1.38 (0.79 - 2.42) 0.80 (0.22 - 2.95) 
 ≥135 2.40 (1.32 - 4.36) 1.51 (0.29 - 7.80) 
Degree of dermal elastosis   
 Nil or Mild Reference Reference 
 Moderate 0.69 (0.42 - 1.12) 0.44 (0.11 - 1.80) 
 Marked 0.51 (0.24 - 1.09) 0.47 (0.13 - 1.70) 
BRAFV600E mutation   
 No Reference Reference 
 Yes 1.73 (0.95 - 3.17) 2.45 (0.58 - 10.26) 
1ORs are adjusted for all variables in the table except for 2moles and total nevus count were not adjusted for each other.  
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Figure legend  
 
Figure 1. Flow chart of study participation and resulting sample for analysis 
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